FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2104845296> ?p ?o ?g. }

• W2104845296 endingPage "614" @default.
• W2104845296 startingPage "614" @default.
• W2104845296 abstract "Onychomycosis, or fungal infection of the nail, can occur in prepubertal children. However, its diagnosis is often missed or the condition is inappropriately treated with topical medication. Griseofulvin has been the therapy of choice, but even long-term treatment is associated with a poor cure rate and high rate of relapse. Trials with adult patients have shown that itraconazole pulse therapy for onychomycosis requires a shorter duration of total therapy than griseofulvin treatment and is rarely associated with adverse reactions, suggesting that it may be the treatment of choice for pediatric patients with onychomycosis.We retrospectively reviewed the courses of prepubertal patients with dermatophyte onychomycosis who initiated treatment with itraconazole pulse therapy between January 1995 and June 1998.Urban and suburban pediatric dermatology clinics of a children's hospital.Seventeen prepubertal patients met the enrollment and follow-up criteria. These included fungal infection of the nail(s), documented by fungal culture and/or positive potassium hydroxide mounts of nail scrapings; at least 1 follow-up visit; and contact by telephone or clinic visit within 2 months prior to compilation of data. In 59% of patients, a relative living at the home had onychomycosis at the time of diagnosis.Patients were treated with daily to twice-daily pulses of itraconazole, administered for 1 week of each of 3 to 5 months.Clinical cure after itraconazole therapy in patients with documented onychomycosis and clinical and mycologic relapse after initial cure. Fungal cultures were not repeated if clinical cure was noted.All but 1 patient responded fully to therapy, showing improvement within a few months and subsequently clearance (94% clinical cure rate). No patients experienced any clinical adverse reactions. No relapses occurred after clinical cure during a follow-up period of 1 to 4.25 years after initiation of therapy.Itraconazole pulse therapy is effective and safe for the treatment of onychomycosis in children. The relapse rate in pediatric patients is lower than in adults, although the high frequency of onychomycosis in non-pediatric family members suggests that the recurrence risk is increased if other family members are not treated concomitantly." @default.
• W2104845296 created "2016-06-24" @default.
• W2104845296 creator A5020095047 @default.
• W2104845296 creator A5049886098 @default.
• W2104845296 date "2000-06-01" @default.
• W2104845296 modified "2023-10-14" @default.
• W2104845296 title "Itraconazole Pulse Therapy for Dermatophyte Onychomycosis in Children" @default.
• W2104845296 cites W1969814158 @default.
• W2104845296 cites W1974984302 @default.
• W2104845296 cites W1975075023 @default.
• W2104845296 cites W1987389138 @default.
• W2104845296 cites W1989617949 @default.
• W2104845296 cites W2018964789 @default.
• W2104845296 cites W2022445574 @default.
• W2104845296 cites W2031205523 @default.
• W2104845296 cites W2035320215 @default.
• W2104845296 cites W2040989511 @default.
• W2104845296 cites W2046884103 @default.
• W2104845296 cites W2066419957 @default.
• W2104845296 cites W2069257350 @default.
• W2104845296 cites W2077489252 @default.
• W2104845296 cites W2078200341 @default.
• W2104845296 cites W2121656686 @default.
• W2104845296 cites W2123325563 @default.
• W2104845296 cites W2128028131 @default.
• W2104845296 cites W2133034396 @default.
• W2104845296 cites W2134495575 @default.
• W2104845296 cites W2166412821 @default.
• W2104845296 cites W2167900242 @default.
• W2104845296 cites W2409424739 @default.
• W2104845296 doi "https://doi.org/10.1001/archpedi.154.6.614" @default.
• W2104845296 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10850511" @default.
• W2104845296 hasPublicationYear "2000" @default.
• W2104845296 type Work @default.
• W2104845296 sameAs 2104845296 @default.
• W2104845296 citedByCount "41" @default.
• W2104845296 countsByYear W21048452962012 @default.
• W2104845296 countsByYear W21048452962013 @default.
• W2104845296 countsByYear W21048452962014 @default.
• W2104845296 countsByYear W21048452962016 @default.
• W2104845296 countsByYear W21048452962017 @default.
• W2104845296 countsByYear W21048452962018 @default.
• W2104845296 countsByYear W21048452962019 @default.
• W2104845296 countsByYear W21048452962020 @default.
• W2104845296 countsByYear W21048452962021 @default.
• W2104845296 crossrefType "journal-article" @default.
• W2104845296 hasAuthorship W2104845296A5020095047 @default.
• W2104845296 hasAuthorship W2104845296A5049886098 @default.
• W2104845296 hasBestOaLocation W21048452961 @default.
• W2104845296 hasConcept C126322002 @default.
• W2104845296 hasConcept C141071460 @default.
• W2104845296 hasConcept C16005928 @default.
• W2104845296 hasConcept C187212893 @default.
• W2104845296 hasConcept C191897082 @default.
• W2104845296 hasConcept C192562407 @default.
• W2104845296 hasConcept C2777071850 @default.
• W2104845296 hasConcept C2777220567 @default.
• W2104845296 hasConcept C2777852167 @default.
• W2104845296 hasConcept C2778236110 @default.
• W2104845296 hasConcept C2779548794 @default.
• W2104845296 hasConcept C2779819575 @default.
• W2104845296 hasConcept C2780651595 @default.
• W2104845296 hasConcept C2994123057 @default.
• W2104845296 hasConcept C535046627 @default.
• W2104845296 hasConcept C71924100 @default.
• W2104845296 hasConceptScore W2104845296C126322002 @default.
• W2104845296 hasConceptScore W2104845296C141071460 @default.
• W2104845296 hasConceptScore W2104845296C16005928 @default.
• W2104845296 hasConceptScore W2104845296C187212893 @default.
• W2104845296 hasConceptScore W2104845296C191897082 @default.
• W2104845296 hasConceptScore W2104845296C192562407 @default.
• W2104845296 hasConceptScore W2104845296C2777071850 @default.
• W2104845296 hasConceptScore W2104845296C2777220567 @default.
• W2104845296 hasConceptScore W2104845296C2777852167 @default.
• W2104845296 hasConceptScore W2104845296C2778236110 @default.
• W2104845296 hasConceptScore W2104845296C2779548794 @default.
• W2104845296 hasConceptScore W2104845296C2779819575 @default.
• W2104845296 hasConceptScore W2104845296C2780651595 @default.
• W2104845296 hasConceptScore W2104845296C2994123057 @default.
• W2104845296 hasConceptScore W2104845296C535046627 @default.
• W2104845296 hasConceptScore W2104845296C71924100 @default.
• W2104845296 hasIssue "6" @default.
• W2104845296 hasLocation W21048452961 @default.
• W2104845296 hasLocation W21048452962 @default.
• W2104845296 hasOpenAccess W2104845296 @default.
• W2104845296 hasPrimaryLocation W21048452961 @default.
• W2104845296 hasRelatedWork W1973245611 @default.
• W2104845296 hasRelatedWork W1996950720 @default.
• W2104845296 hasRelatedWork W2023625435 @default.
• W2104845296 hasRelatedWork W2029928367 @default.
• W2104845296 hasRelatedWork W2036214634 @default.
• W2104845296 hasRelatedWork W2043709808 @default.
• W2104845296 hasRelatedWork W2147481118 @default.
• W2104845296 hasRelatedWork W2463449047 @default.
• W2104845296 hasRelatedWork W4229676201 @default.
• W2104845296 hasRelatedWork W4244144176 @default.
• W2104845296 hasVolume "154" @default.
• W2104845296 isParatext "false" @default.

• next